Erez Raphael - DarioHealth Corp Chairman, CEO and Pres
| DRIO Stock | USD 11.53 0.02 0.17% |
Chairman
Mr. Erez Raphael is Chief Executive Officer, Director of the Company. He has served as our Chief Executive Officer since August 9, 2013 and as a director of our Company since December 2013. Mr. Raphael has served as Chairman of the Board of Directors since November 2014. He previously and since October 2012 served as our Vice President of Research and Development. Mr. Raphael has over 17 years of industry experience, having been responsible in his career for product delivery, technology and business development. Prior to joining us, from 2010 to 2012, Mr. Raphael served as Head of Business Operations for Nokia Siemens Networks, where he was responsible for establishing and implementing a new portfolio business unit directed towards marketing and sales of complimentary products. Prior to that, from 1998 to 2010, he held increasingly senior positions at Amdocs Limited where he was ultimately responsible for advising the Chief Technology Officer and implementing matters of overall business strategy since 2018.
| Age | 53 |
| Tenure | 8 years |
| Address | 322 W 57th Street, New York, NY, United States, 10019 |
| Phone | 972 4 770 6377 |
| Web | https://www.dariohealth.com |
Latest Insider Transactions
Raphael holds a B.A. in economics and business management from Haifa University. We believe Mr. Raphael is qualified to serve on our Board because of his extensive experience with technology companies and in sales and marketing.Erez Raphael Latest Insider Activity
Tracking and analyzing the buying and selling activities of Erez Raphael against DarioHealth Corp stock is an integral part of due diligence when investing in DarioHealth Corp. Erez Raphael insider activity provides valuable insight into whether DarioHealth Corp is net buyers or sellers over its current business cycle. Note, DarioHealth Corp insiders must abide by specific rules, including filing SEC forms every time they buy or sell DarioHealth Corp'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Erez Raphael over three months ago Disposition of 7857 shares by Erez Raphael of DarioHealth Corp at 18.4907 subject to Rule 16b-3 | ||
Erez Raphael over six months ago Acquisition by Erez Raphael of 5000 shares of DarioHealth Corp at 0.95 subject to Rule 16b-3 | ||
Erez Raphael over a year ago Acquisition by Erez Raphael of 5000 shares of DarioHealth Corp at 0.88 subject to Rule 16b-3 | ||
Erez Raphael over a year ago Acquisition by Erez Raphael of 5000 shares of DarioHealth Corp at 0.95 subject to Rule 16b-3 |
DarioHealth Corp Management Efficiency
The company has return on total asset (ROA) of (0.2143) % which means that it has lost $0.2143 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6342) %, meaning that it created substantial loss on money invested by shareholders. DarioHealth Corp's management efficiency ratios could be used to measure how well DarioHealth Corp manages its routine affairs as well as how well it operates its assets and liabilities. As of the 18th of February 2026, Return On Tangible Assets is likely to drop to -0.95. In addition to that, Return On Capital Employed is likely to drop to -0.53. At this time, DarioHealth Corp's Fixed Asset Turnover is very stable compared to the past year. As of the 18th of February 2026, Asset Turnover is likely to grow to 0.35, while Total Current Assets are likely to drop about 24.5 M.Similar Executives
| Found 2 records | CHAIRMAN Age | ||
| Gary Blackford | Avanos Medical | 63 | |
| Ming Hsieh | Fulgent Genetics | 70 | |
Management Performance
| Return On Equity | -0.63 | ||||
| Return On Asset | -0.21 |
DarioHealth Corp Leadership Team
Elected by the shareholders, the DarioHealth Corp's board of directors comprises two types of representatives: DarioHealth Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of DarioHealth. The board's role is to monitor DarioHealth Corp's management team and ensure that shareholders' interests are well served. DarioHealth Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, DarioHealth Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Lara Dodo, Chief Officer | ||
| Michal AbermanShimon, Chief Officer | ||
| Tomer BenKiki, Chief Officer | ||
| Zvi CPA, Treasurer CFO | ||
| Josh Fischer, Senior Compliance | ||
| Zoe Harrison, VP Development | ||
| Dov Oppenheim, CoFounder Chief | ||
| Brian Harrigan, Senior Sales | ||
| Richard Anderson, President | ||
| Claudia Levi, Content Manager | ||
| Jean Muyl, Head America | ||
| Zvi David, Treasurer CFO | ||
| Kat Parrella, Investor Manager | ||
| Chen FrancoYehuda, Treasurer CFO | ||
| Steven Nelson, President Officer | ||
| Dror Bacher, Chief Officer | ||
| Erez Raphael, Chairman, CEO and Pres | ||
| Mona Dean, Chief Officer | ||
| Rob Halpern, SVP Marketing | ||
| Mary Mooney, Vice Marketing | ||
| Limor Drezner, Chief Officer | ||
| Olivier Jarry, President and Chief Commercial Officer | ||
| Omar MD, Chief Officer |
DarioHealth Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is DarioHealth Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.63 | ||||
| Return On Asset | -0.21 | ||||
| Profit Margin | (1.71) % | ||||
| Operating Margin | (1.89) % | ||||
| Current Valuation | 78.94 M | ||||
| Shares Outstanding | 6.76 M | ||||
| Shares Owned By Insiders | 23.20 % | ||||
| Shares Owned By Institutions | 11.40 % | ||||
| Number Of Shares Shorted | 64.68 K | ||||
| Price To Earning | (2.30) X |
Pair Trading with DarioHealth Corp
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DarioHealth Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DarioHealth Corp will appreciate offsetting losses from the drop in the long position's value.Moving against DarioHealth Stock
The ability to find closely correlated positions to DarioHealth Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DarioHealth Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DarioHealth Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DarioHealth Corp to buy it.
The correlation of DarioHealth Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DarioHealth Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DarioHealth Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DarioHealth Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DarioHealth Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Will Health Care Technology sector continue expanding? Could DarioHealth diversify its offerings? Factors like these will boost the valuation of DarioHealth Corp. Projected growth potential of DarioHealth fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every DarioHealth Corp data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (10.87) | Revenue Per Share | Quarterly Revenue Growth (0.33) | Return On Assets | Return On Equity |
DarioHealth Corp's market price often diverges from its book value, the accounting figure shown on DarioHealth's balance sheet. Smart investors calculate DarioHealth Corp's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since DarioHealth Corp's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between DarioHealth Corp's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DarioHealth Corp should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.